TRANSCON
LIVE

Serial Number

79221044

Owner

Ascendis Pharma A/S

Attorney

Shannon Marie McKeon

Filing Date

Jul 17, 2017

Add to watchlist:

No watchlists yet
View on USPTO

TRANSCON Trademark

Serial Number: 79221044 • Registration: 5881763

TRANSCON is a trademark filed by Ascendis Pharma A/S on July 17, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). The application is currently registered and active.

Owner Contact Info

Ascendis Pharma A/S (9 trademarks)

Tuborg Boulevard 5
Hellerup 2900 , DK

Entity Type: 16

Trademark Details

Filing Date

July 17, 2017

Registration Date

October 15, 2019

Published for Opposition

July 30, 2019

Goods & Services

[ Licensing of industrial property rights; legal services ]

Scientific research within the medical, pharmaceutical and bacteriological area and consultancy and information relating thereto; conducting of tests regarding medical applications in the nature of providing medical testing services in the field of sustained release of pharmaceutical and veterinary drugs; designing and development of medical equipment; designing pharmaceutical and medical preparations in the nature of pharmaceutical drug development services; development of pharmaceutical formulations; design and development of pharmaceutical granulation technology and pharmaceutical tablet technology and consultancy and information relating thereto

Pharmaceutical and veterinary preparations, namely, a drug delivery system in the form of polymer based prodrug formulations which allow for the controlled or continuous release of a wide variety of therapeutic agents for the treatment of mental illness and physical illness in the nature of disorder of the endocrine system, growth hormone deficiency, hypoparathyroidism, achondroplasia, diabetes, fibroblast growth factor receptor (FGFR)-related skeletal disorders, oncology, ophthalmology, infectious disease, enzyme replacement therapy, anti-inflammatory disease, pain, respiratory system disorder, autoimmune disorders, vaccines, non-alcoholic steatohepatitis, brain diseases, bone diseases, CNS diseases, myopathies, obesity, wound healing; sanitary preparations for medical purposes; dietetic substances adapted for medical use; disinfectants; fungicides; herbicides

Filing History

POST REGISTRATION ACTION MAILED - SEC.71
Mar 10, 2026 PR71
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 8, 2026 APRE
TEAS SECTION 71 RECEIVED
Oct 31, 2025 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 15, 2024 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Mar 10, 2024 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Dec 24, 2021 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Oct 28, 2021 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 21, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 4, 2020 FICS
FINAL DISPOSITION PROCESSED
Feb 3, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 15, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 15, 2019 R.PR
NOTIFICATION PROCESSED BY IB
Aug 23, 2019 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 30, 2019 NPUB
PUBLISHED FOR OPPOSITION
Jul 30, 2019 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 10, 2019 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 10, 2019 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 10, 2019 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 21, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 20, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 20, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 20, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 20, 2019 CNEA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 3, 2019 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 17, 2019 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 17, 2019 OPNR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 11, 2019 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 11, 2018 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 11, 2018 GNSL
SUSPENSION LETTER WRITTEN
Jul 11, 2018 CNSL
EXAMINER'S AMENDMENT ENTERED
Jul 11, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 11, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 11, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 11, 2018 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 21, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 21, 2018 CRFA
ASSIGNED TO LIE
Jun 20, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 6, 2018 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 23, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 23, 2018 REAP
REFUSAL PROCESSED BY IB
Dec 29, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 8, 2017 RFCS
REFUSAL PROCESSED BY MPU
Dec 8, 2017 RFRR
APPLICATION FILING RECEIPT MAILED
Nov 28, 2017 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 26, 2017 RFCR
NON-FINAL ACTION WRITTEN
Nov 25, 2017 CNRT
ASSIGNED TO EXAMINER
Nov 22, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 22, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 16, 2017 REPR